We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIAI
451
DELISTED
Prime Impact Acquisition I
PIAI
-149,997
Closed -$1.51M
GFX.U
452
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
-75,000
Closed -$780K
BNGOW
453
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
-70,621
Closed -$148K
KDNY
454
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-272,949
Closed -$4.33M
ARBGU
455
DELISTED
Aequi Acquisition Corp Unit
ARBGU
-350,000
Closed -$3.54M
SNRHU
456
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
-1,000,000
Closed -$10.3M
SGTX
457
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-43,202
Closed -$27M
OSH
458
DELISTED
Oak Street Health, Inc.
OSH
-80,000
Closed -$4.89M
EUCRU
459
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
-300,000
Closed -$3.2M
GLS
460
DELISTED
Gelesis Holdings, Inc.
GLS
-199,998
Closed -$2.03M
VLTA
461
DELISTED
Volta Inc.
VLTA
-100,000
Closed -$1.06M
KINZU
462
DELISTED
KINS Technology Group Inc. Unit
KINZU
-75,000
Closed -$772K
FPAC.U
463
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
-250,000
Closed -$2.59M
HPX
464
DELISTED
HPX Corp.
HPX
-199,998
Closed -$2M
CTAQU
465
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
-200,000
Closed -$2.05M
SCOAU
466
DELISTED
ScION Tech Growth I Unit
SCOAU
-200,000
Closed -$2.06M
PCPC.U
467
DELISTED
Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
PCPC.U
-150,000
Closed -$3.92M
HMCOU
468
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
-100,000
Closed -$1.1M
PHICU
469
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
-100,000
Closed -$1.04M
JYAC
470
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
-200,000
Closed -$2.06M
FLACU
471
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
-150,000
Closed -$1.56M
PIPP.U
472
DELISTED
Pine Island Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
PIPP.U
-250,000
Closed -$2.58M
SRSA
473
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
-299,994
Closed -$3.04M
BLSA
474
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
-115,000
Closed -$1.28M
LFTRU
475
DELISTED
Lefteris Acquisition Corp. Unit
LFTRU
-400,000
Closed -$4.34M

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.